Indian oncology medicine manufacturers are witnessing a clear disconnect between rapid scientific innovation — including targeted therapies, biosimilars, next-generation sequencing (NGS), minimal residual disease assays, and immuno-oncology treatm...
India is facing a growing public health concern as energy drinks are increasingly being linked to liver damage in young adults. Doctors across the country report a noticeable rise in patients in their 20s and 30s showing early signs of liver...
India may see a rise in medicine prices as the West Asia conflict drives up raw material and logistics costs, impacting pharma companies and raising concerns over supply and affordability.
The India pharma startups ecosystem is stepping into a defining decade. For years, it powered global healthcare as the “Pharmacy of the World,” supplying cost-effective generics at unmatched scale. But in 2026, that identity is no longer enough.
India’s pharmaceutical exports registered a sharp 23% year-on-year decline in March 2026, marking the first monthly drop in the last three financial years. According to quick estimates from the Ministry of Commerce and Industry, drug shipment...
India has taken an important step in global health collaboration by chairing the first BRICS Health Working Group (HWG) meeting for 2026. The meeting, held in New Delhi, brought together health officials and experts from member countries to discus...
Novo Nordisk’s weight loss drug has shown promising liver benefits in a new preclinical study, pointing to effects beyond just shedding pounds. Researchers found that the company’s GLP-1-based treatment improved liver health in mice, even when...
The Bajaj Group has announced its entry into India’s healthcare sector with an investment of ?2,000–?2,500 crore to build an integrated healthcare network. This move marks a major diversification for the long-established business grou...
The essential drugs price hike due to Iran war is starting to reflect in India’s pharmaceutical market, with reports indicating that prices of key medicines may rise by up to 5 percent in the near term.
India’s INR 10,000 crore startup fund boosts health tech and medtech startups, giving a strong push to innovation in critical healthcare areas. Announced as part of the government’s renewed funding strategy, the initiative is designed to channel...
.jpg)
, CDSCO.jpg)